371 related articles for article (PubMed ID: 33806685)
1. Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021.
Lange M; Hartmann K; Carter MC; Siebenhaar F; Alvarez-Twose I; Torrado I; Brockow K; Renke J; Irga-Jaworska N; Plata-Nazar K; Ługowska-Umer H; Czarny J; Belloni Fortina A; Caroppo F; Nowicki RJ; Nedoszytko B; Niedoszytko M; Valent P
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33806685
[TBL] [Abstract][Full Text] [Related]
2. Pediatric Mastocytosis: An Update.
Giona F
Mediterr J Hematol Infect Dis; 2021; 13(1):e2021069. PubMed ID: 34804443
[TBL] [Abstract][Full Text] [Related]
3. [Mastocytosis in children].
Wassmer H; Hartmann K
Dermatologie (Heidelb); 2023 May; 74(5):323-329. PubMed ID: 37140636
[TBL] [Abstract][Full Text] [Related]
4. Mastocytosis: a comprehensive insight.
VAN Gysel D; DE Maeseneer H; Oranje AP
G Ital Dermatol Venereol; 2016 Aug; 151(4):385-96. PubMed ID: 27070304
[TBL] [Abstract][Full Text] [Related]
5. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
[TBL] [Abstract][Full Text] [Related]
6. [Systemic mastocytosis. Classification, symptoms, therapy].
Kraemer DM; Grunewald SM; Kolb-Mäurer A
Med Klin (Munich); 2004 Mar; 99(3):131-6. PubMed ID: 15024485
[TBL] [Abstract][Full Text] [Related]
7. [Mastocytosis: revisited with new cytogenetic data].
Vaes M; Vereecken P; de Wind R; Andry G; Li R; Bron D
Rev Med Brux; 2012; 33(1):12-21. PubMed ID: 22512145
[TBL] [Abstract][Full Text] [Related]
8. Kit Mutations: New Insights and Diagnostic Value.
Falchi L; Verstovsek S
Immunol Allergy Clin North Am; 2018 Aug; 38(3):411-428. PubMed ID: 30007460
[TBL] [Abstract][Full Text] [Related]
9. [An infant with macules and papules].
van der Waa JD; Vredenborg AD
Ned Tijdschr Geneeskd; 2020 Aug; 164():. PubMed ID: 32940988
[TBL] [Abstract][Full Text] [Related]
10. Mastocytosis and related disorders.
Chiu A; Orazi A
Semin Diagn Pathol; 2012 Feb; 29(1):19-30. PubMed ID: 22372203
[TBL] [Abstract][Full Text] [Related]
11. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
12. An Unusual Transition from Cutaneous to Systemic Mastocytosis in a Pediatric Patient.
Patel K; Cuervo-Pardo L; Cresoe S; Cavero-Chavez V
Pediatr Allergy Immunol Pulmonol; 2023 Dec; 36(4):150-152. PubMed ID: 38134319
[No Abstract] [Full Text] [Related]
13. Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions.
Valent P; Akin C; Bonadonna P; Brockow K; Niedoszytko M; Nedoszytko B; Butterfield JH; Alvarez-Twose I; Sotlar K; Schwaab J; Jawhar M; Reiter A; Castells M; Sperr WR; Kluin-Nelemans HC; Hermine O; Gotlib J; Zanotti R; Broesby-Olsen S; Horny HP; Triggiani M; Siebenhaar F; Orfao A; Metcalfe DD; Arock M; Hartmann K
J Allergy Clin Immunol; 2020 Aug; 146(2):300-306. PubMed ID: 32561389
[TBL] [Abstract][Full Text] [Related]
14. Mastocytosis and related entities: a practical roadmap.
Beyens M; Elst J; van der Poorten ML; Van Gasse A; Toscano A; Verlinden A; Vermeulen K; Maes MB; Oude Elberink JNGH; Ebo D; Sabato V
Acta Clin Belg; 2023 Aug; 78(4):325-335. PubMed ID: 36259506
[TBL] [Abstract][Full Text] [Related]
15. Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.
Álvarez-Twose I; Jara-Acevedo M; Morgado JM; García-Montero A; Sánchez-Muñoz L; Teodósio C; Matito A; Mayado A; Caldas C; Mollejo M; Orfao A; Escribano L
J Allergy Clin Immunol; 2016 Jan; 137(1):168-178.e1. PubMed ID: 26100086
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment with Omalizumab of a child affected by Systemic Mastocytosis: clinical and biological implications.
Bossi G; Brazzelli V; De Amici M; Pietra D; Raviola C; Naso M; Regalbuto C; Boselli F; Fortina V; Marseglia GL
Ital J Pediatr; 2023 Jan; 49(1):6. PubMed ID: 36639823
[TBL] [Abstract][Full Text] [Related]
17. Role of imatinib in the treatment of pediatric onset indolent systemic mastocytosis: a case report.
Agarwala MK; George R; Mathews V; Balasubramanian P; Thomas M; Nair S
J Dermatolog Treat; 2013 Dec; 24(6):481-3. PubMed ID: 23659595
[TBL] [Abstract][Full Text] [Related]
18. Mastocytosis.
Abid A; Malone MA; Curci K
Prim Care; 2016 Sep; 43(3):505-18. PubMed ID: 27545739
[TBL] [Abstract][Full Text] [Related]
19. [Systemic mastocytosis].
Fain O; Stirnemann J; Eclache V; Barete S; Casassus P; Hermine O; Lorholary O
Presse Med; 2005 May; 34(9):681-7. PubMed ID: 15988348
[TBL] [Abstract][Full Text] [Related]
20. Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis.
Aberer E; Sperr WR; Bretterklieber A; Avian A; Hadzijusufovic E; Kluin-Nelemans HC; Oude Elberink H; van Anrooij B; Niedoszytko M; Lange M; Górska A; Elena C; Brazzelli V; Belloni Fortina A; Caroppo F; Hartmann K; Illerhaus A; Reiter A; Jawhar M; Bonadonna P; Zanotti R; Triggiani M; Parente R; Gotlib J; Doubek M; von Bubnoff N; Fuchs D; Sabato V; Brockow K; Jäkel N; Panse J; Valent P
J Invest Dermatol; 2021 Jul; 141(7):1719-1727. PubMed ID: 33581142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
